Pharming Group (PHARM) Stock Statistics & Valuation Metrics

Pharming Group has a market cap or net worth of €798.07M. The enterprise value is €980.20M.

Pharming Group has 706,252,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Pharming Group’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 0.88%.

The current PE Ratio of Pharming Group is 77.0. Pharming Group’s PEG ratio is -2.77.

In the last 12 months, Pharming Group had revenue of 376.13M and earned 2.97M in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 52.63M and capital expenditures -707.01K, giving a free cash flow of 51.92M billion.

Pharming Group pays an annual dividend of ―, resulting in a dividend yield of ―

Pharming Group upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).

Pharming Group as a current ratio of 2.59, with Debt / Equity ratio of 43.21%

In the past 12 months, Pharming Group has paid 10.73M in taxes.

Pharming Group EV to EBITDA ratio is 28.80, with an EV/FCF ratio of 19.57.

Pharming Group has €170.72M in cash and marketable securities with €116.08M in debt, giving a net cash position of €54.64M billion.

Gross margin is 88.12%, with operating margin of 5.55%, and net profit margin of 0.79%.

The average price target for Pharming Group is ―, which is 11.43% higher than the current price. The consensus rating is ―